Trial Design, Treatment Options Spotlighted in Xylazine Conference

(MedPage Today) -- Longer observation periods following treatment and safety considerations for chronic and frequent users are among the many research issues about xylazine-laced fentanyl that need addressing, Rachel Wightman, MD, said at a meeting...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news